Eighth International Symposium on Regional Cancer Therapies
February 16—18, 2013
Hyatt Grand Champion Resort & Spa - Indian Wells, California
Poster winners from 2013 Conference in Captiva
First Place
Does Obesity Affect Outcomes of Cytoreduction Surgery for Mucinous Appendiceal Neoplasia
Patricio Polanco, MD
University of Pittsburgh
Second Place - TIE
KRAS status is a prognostic variable in cytoreductive surgery/HIPEC for colorectal cancer carcinomatosis
Deepa Magge, MD
University of Pittsburgh
KRAS Mutation is Associated with Favorable Prognosis among Patients with Appendiceal Carcinomatosis
Patrick Wagner, MD
Valley Health
Winchester, Virginia
Third Place
Mechanical Bowel Prep Prior to Cytoreductive Surgey with HIPEC May Reduce Wound Infection Rates
Sara McPartland, MD
Tufts Medical Center
Boston, Massachusetts
Presented by the David C. Koch Regional Cancer Therapy Center of the University of Pittsburgh Cancer Centers.
Meeting Dates and Goals:
The Eighth International Symposium on Regional Cancer Therapies will take place February 16 - 18, 2013 at Hyatt Grand Champion Resort & Spa, Indian Wells, California. The Symposium is sponsored by the David C. Koch Regional Cancer Therapy Center, the University of Pittsburgh School of Medicine Center for Continuing Education in the Health Sciences and UPMC Cancer Centers.
The Koch Regional Cancer Therapy Center is committed to:
- Promoting Research, Development and Application of Regional Cancer Therapies
- Exchanging Information and Promoting Education Among Professionals regarding Regional Cancer Therapies
The Eighth International Symposium will serve as a comprehensive forum to achieve these goals.
Target Audience:
The target audience includes physicians and nurses practicing in the areas of medical, surgical, thoracic and gynecologic oncology and gastroenterology and researchers involved in the field of hyperthermia and regionally applied biologic therapies.
Disclosure of Conflict of Interest:
It is the policy of University of Pittsburgh that the information presented at University of Pittsburgh sponsored CME activities will be unbiased and based on scientific evidence. To help participants make judgments about the presence of bias, the University of Pittsburgh will provide information that speakers have disclosed about financial relationships they have with commercial entities that produce or market products or services related to the content of this CME activity, All authors must complete a disclose form regarding financial or other interests in the work they intend to present or to confirm that no such relationship exists
Review Process:
Abstracts/Posters will be reviewed by the SPC and, if selected, will be made part of the oral presentation agenda. Oral presentations are formal, LCD/Power-Point presentations, approximately 20 minutes in length, followed by a short discussion period.
For further information, please contact:
Maureen Hewko, MBA
Program Manager
David C. Koch Regional Cancer Therapy Center
UPMC Cancer Pavilion, Suite 413
5150 Centre Avenue
Pittsburgh, PA 15232
Phone: 412.623.5993
Fax: 412.692.2520
hewkom@upmc.edu